Victoria Baltrus Sells 1,523 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 1,523 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $33,414.62. Following the completion of the transaction, the chief accounting officer owned 214,589 shares of the company’s stock, valued at approximately $4,708,082.66. The trade was a 0.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Up 4.2%

NYSE:OSCR opened at $24.59 on Friday. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $25.58. The firm has a market capitalization of $7.41 billion, a P/E ratio of -41.68, a P/E/G ratio of 1.65 and a beta of 2.37. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The business has a 50 day simple moving average of $18.39 and a 200 day simple moving average of $16.06.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business’s revenue for the quarter was up 52.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 EPS. Equities research analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current year.

Institutional Trading of Oscar Health

A number of hedge funds and other institutional investors have recently modified their holdings of OSCR. Jones Financial Companies Lllp raised its stake in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio bought a new stake in shares of Oscar Health in the 1st quarter worth $30,000. Fifth Third Bancorp raised its stake in shares of Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after buying an additional 1,413 shares in the last quarter. Quarry LP raised its stake in shares of Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after buying an additional 1,469 shares in the last quarter. Finally, Tsfg LLC bought a new stake in shares of Oscar Health in the 3rd quarter worth $38,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health News Summary

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com
• Positive Sentiment: Oscar Health’s recent earnings showed a major EPS beat, which supports the stock’s fundamental story despite revenue coming in below estimates.
• Neutral Sentiment: A company co-founder shifting into an advisory leadership role looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley and CAO Victoria Baltrus, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.
• Negative Sentiment: Director Mario Schlosser sold 34,120 shares, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.

Analyst Ratings Changes

A number of equities research analysts have issued reports on OSCR shares. Barclays raised their target price on Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 26th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Wells Fargo & Company set a $20.00 target price on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday. Finally, Robert W. Baird raised their target price on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Oscar Health presently has an average rating of “Hold” and an average price target of $20.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.